Medesis Pharma SA
F:76D
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medesis Pharma SA
F:76D
|
FR |
Bankruptcy Probability
Medesis Pharma SA's probability of bankruptcy is 3%, pointing to a small but noticeable default risk. The solvency score is 53/100 — a warning sign of potential financial weakness.
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Medesis Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Medesis Pharma SA
PAR:ALMDP
|
1.8m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Space Exploration Technologies Corp
NASDAQ:SPCX
|
1.8T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
253.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
BlackRock New York Municipal Income Trust
NYSE:BNY
|
110.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
105.6B ZAR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
79.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
72.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
61.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
40.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Medesis Pharma SA's probability of bankruptcy is 3%, pointing to a small but noticeable default risk.
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Medesis Pharma SA has total debt of 1.3m EUR. This includes both short-term (0 EUR) and long-term (1.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
